Tumor Markers
Serology-based tumour marker panel results and trending
Critical result: SCC-Ag 18.4 ng/mL — Kavitha Nair. Notify requesting clinician immediately.
Kavitha Nair, 55F
TM-2026-0441 · Dr. K. Rao (ENT/Oncology MDT) — suspected laryngeal carcinoma
| Marker | Value | Unit | Reference | Flag | Note |
|---|---|---|---|---|---|
| SCC-Ag | 18.4 | ng/mL | < 1.5 | Critical | Markedly elevated — squamous cell carcinoma antigen |
| CEA | 3.2 | ng/mL | < 5.0 | Normal | — |
| CA 125 | 28 | U/mL | < 35 | Normal | — |
| CA 19-9 | 22 | U/mL | < 37 | Normal | — |
SCC-Ag markedly elevated (18.4 ng/mL) — strongly correlates with squamous cell carcinoma. CEA, CA125, CA19-9 within normal limits. Clinical correlation with laryngoscopy and biopsy essential.
Anil Mehta, 62M
TM-2026-0440 · Dr. P. Nair (Urology) — post-prostatectomy surveillance
| Marker | Value | Unit | Reference | Flag | Note |
|---|---|---|---|---|---|
| PSA (Total) | 0.08 | ng/mL | Undetectable post-RP (< 0.2) | Normal | Biochemical remission maintained |
| PSA Velocity | Stable | — | < 0.75 ng/mL/yr | Normal | — |
| AFP | 4.1 | ng/mL | < 8.1 | Normal | — |
PSA remains undetectable at 0.08 ng/mL — no evidence of biochemical recurrence. Continue surveillance per protocol (6-monthly PSA).